Salem Investment Counselors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $546K | Hold |
1,411
| – | – | 0.01% | 298 |
|
|
2026
Q1 | $413K | Buy |
1,411
+101
| +8% | +$33.2K | 0.01% | 298 |
|
|
2025
Q4 | $459K | Sell |
1,310
-1
| -0.1% | -$338 | 0.01% | 288 |
|
|
2025
Q3 | $424K | Hold |
1,311
| – | – | 0.01% | 298 |
|
|
2025
Q2 | $510K | Hold |
1,311
| – | – | 0.02% | 274 |
|
|
2025
Q1 | $570K | Hold |
1,311
| – | – | 0.02% | 247 |
|
|
2024
Q4 | $484K | Sell |
1,311
-4
| -0.3% | -$1.67K | 0.02% | 267 |
|
|
2024
Q3 | $684K | Buy |
1,315
+4
| +0.3% | +$2.14K | 0.02% | 238 |
|
|
2024
Q2 | $710K | Sell |
1,311
-58
| -4% | -$30.7K | 0.02% | 229 |
|
|
2024
Q1 | $710K | Buy |
1,369
+58
| +4% | +$28.8K | 0.02% | 225 |
|
|
2023
Q4 | $618K | Buy |
1,311
+83
| +7% | +$38.4K | 0.02% | 229 |
|
|
2023
Q3 | $535K | Sell |
1,228
-50
| -4% | -$22.7K | 0.02% | 235 |
|
|
2023
Q2 | $568K | Sell |
1,278
-140
| -10% | -$64.6K | 0.02% | 225 |
|
|
2023
Q1 | $652K | Sell |
1,418
-50
| -3% | -$23.8K | 0.03% | 219 |
|
|
2022
Q4 | $753K | Sell |
1,468
-157
| -10% | -$79.7K | 0.03% | 206 |
|
|
2022
Q3 | $738K | Hold |
1,625
| – | – | 0.03% | 197 |
|
|
2022
Q2 | $784K | Buy |
1,625
+131
| +9% | +$64.8K | 0.04% | 200 |
|
|
2022
Q1 | $734K | Sell |
1,494
-12
| -0.8% | -$5.49K | 0.03% | 216 |
|
|
2021
Q4 | $698K | Buy |
1,506
+492
| +49% | +$207K | 0.02% | 235 |
|
|
2021
Q3 | $378K | Hold |
1,014
| – | – | 0.02% | 276 |
|
|
2021
Q2 | $387K | Buy |
1,014
+190
| +23% | +$72.6K | 0.02% | 267 |
|
|
2021
Q1 | $296K | Buy |
824
+69
| +9% | +$22.2K | 0.02% | 253 |
|
|
2020
Q4 | $242K | Buy |
755
+5
| +0.7% | +$1.53K | 0.02% | 263 |
|
|
2020
Q3 | $201K | Hold |
750
| – | – | 0.02% | 245 |
|
|
2020
Q2 | $197K | Hold |
750
| – | – | 0.02% | 245 |
|
|
2020
Q1 | $170K | Hold |
750
| – | – | 0.02% | 241 |
|
|
2019
Q4 | $227K | Hold |
750
| – | – | 0.02% | 234 |
|
|
2019
Q3 | $180K | Hold |
750
| – | – | 0.02% | 250 |
|
|
2019
Q2 | $212K | Hold |
750
| – | – | 0.02% | 242 |
|
|
2019
Q1 | $206K | Buy |
+750
| New | +$217K | 0.02% | 190 |
|
|
2018
Q4 | – | Sell |
-750
| Closed | -$206K | – | 240 |
|
|
2018
Q3 | $206K | Hold |
750
| – | – | 0.02% | 190 |
|
|
2018
Q2 | $179K | Hold |
750
| – | – | 0.02% | 200 |
|
|
2018
Q1 | $167K | Hold |
750
| – | – | 0.02% | 196 |
|
|
2017
Q4 | $169K | Buy |
750
+50
| +7% | +$10.6K | 0.02% | 201 |
|
|
2017
Q3 | $133K | Sell |
700
-10
| -1% | -$1.9K | 0.02% | 216 |
|
|
2017
Q2 | $134K | Buy |
710
+10
| +1% | +$1.8K | 0.02% | 227 |
|
|
2017
Q1 | $116K | Hold |
700
| – | – | 0.01% | 282 |
|
|
2016
Q4 | $101K | Hold |
700
| – | – | 0.01% | 292 |
|
|
2016
Q3 | $877 | Buy |
+700
| New | +$90.4K | 0.01% | 272 |
|
Other funds holding ELV
AACR
HGIM
FI
DC
CF
Salem Investment Counselors's ELV Position: Q2 2026 in Review
Salem Investment Counselors held its Elevance Health (ELV) position steady in Q2 2026 at 1,411 shares worth $546K. The position accounts for 0.01% of the portfolio, ranked #298.
Salem Investment Counselors first reported a position in ELV in Q3 2016 and has held it in 39 quarters since. The position peaked at $784K in Q2 2022. 640 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Salem Investment Counselors held 1,411 shares of Elevance Health worth $546K as of Q2 2026.
- Salem Investment Counselors left its Elevance Health share count unchanged in Q2 2026.
- Elevance Health made up 0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #298 holding.
- Salem Investment Counselors first reported a position in Elevance Health in Q3 2016 and has held it in 39 quarters since.
- Salem Investment Counselors's Elevance Health position peaked at $784K in Q2 2022.
- 640 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.